Liver Cancer Diagnostic Market (By Screening Type: Laboratory Tests [Biomarkers {Oncofetal and Glycoprotein Antigens, Enzymes and Isoenzymes, Growth Factors and Receptors, Molecular Markers, Pathological Biomarkers}, Blood Tests], Imaging, Endoscopy, Biopsy, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format: PDF | Status: Published | Pages : 160

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
       1.1.1. Definition of Liver Cancer Diagnostic
       1.1.2. Market Segmentation
       1.1.3. List of Abbreviations
1.2. Summary
       1.2.1. Market Snapshot
       1.2.2. Liver Cancer Diagnostic Market By Screening Type
                 1.2.2.1. Global Liver Cancer Diagnostic Market Revenue and Growth Rate Comparison By Screening Type (2015-2026)
                 1.2.2.2. Global Liver Cancer Diagnostic Market Revenue Share By Screening Type in 2017
                 1.2.2.3. Laboratory Tests
                 1.2.2.4. Imaging
                 1.2.2.5. Endoscopy
                 1.2.2.6. Biopsy
                 1.2.2.7. Others
       1.2.3. Liver Cancer Diagnostic Market by Geography
                 1.2.3.1. Global Liver Cancer Diagnostic Market Revenue and Growth Rate Comparison by Geography (2015-2026)
                 1.2.3.2. North America Liver Cancer Diagnostic Market Revenue and Growth Rate (2015-2026)
                 1.2.3.3. Europe Liver Cancer Diagnostic Market Revenue and Growth Rate (2015-2026)
                 1.2.3.4. Asia-Pacific Liver Cancer Diagnostic Market Revenue and Growth Rate (2015-2026)
                 1.2.3.5. Latin America Liver Cancer Diagnostic Market Revenue and Growth Rate (2015-2026)
                 1.2.3.6. Middle East and Africa (MEA) Liver Cancer Diagnostic Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
       2.4.1. Bargaining Power of Suppliers
       2.4.2. Bargaining Power of Buyers
       2.4.3. Threat of Substitute
       2.4.4. Threat of New Entrants
       2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
       2.6.1. Raw Material and Suppliers
       2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
       2.8.1. Player Positioning Analysis
       2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Liver Cancer Diagnostic Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Liver Cancer Diagnostic Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Liver Cancer Diagnostic Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Liver Cancer Diagnostic Major Manufacturers in 2017

CHAPTER 4. LIVER CANCER DIAGNOSTIC MARKET BY SCREENING TYPE

4.1. Global Liver Cancer Diagnostic Revenue By Screening Type
4.2. Laboratory Tests
       4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Imaging
       4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Endoscopy
       4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Biopsy
       4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.6. Others
       4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. NORTH AMERICA LIVER CANCER DIAGNOSTIC MARKET BY COUNTRY

5.1. North America Liver Cancer Diagnostic Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2. North America Liver Cancer Diagnostic Market Revenue Share Comparison, 2015 & 2026 (%)
5.3. U.S.
       5.3.1. U.S. Liver Cancer Diagnostic Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
       5.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
5.4. Canada
       5.4.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
       5.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
5.5. Mexico
       5.5.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
       5.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 6. EUROPE LIVER CANCER DIAGNOSTIC MARKET BY COUNTRY

6.1. Europe Liver Cancer Diagnostic Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2. Europe Liver Cancer Diagnostic Market Revenue Share Comparison, 2015 & 2026 (%)
6.3. UK
       6.3.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
       6.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
6.4. Germany
       6.4.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
       6.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
6.5. France
       6.5.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
       6.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
6.6. Spain
       6.6.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
       6.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
6.7. Rest of Europe
       6.7.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
       6.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 7. ASIA-PACIFIC LIVER CANCER DIAGNOSTIC MARKET BY COUNTRY

7.1. Asia-Pacific Liver Cancer Diagnostic Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. Asia-Pacific Liver Cancer Diagnostic Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. China
       7.3.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
       7.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.4. Japan
       7.4.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
       7.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.5. India
       7.5.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
       7.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.6. Australia
       7.6.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
       7.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.7. South Korea
       7.7.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
       7.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.8. Rest of Asia-Pacific
       7.8.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
       7.8.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 8. LATIN AMERICA LIVER CANCER DIAGNOSTIC MARKET BY COUNTRY

8.1. Latin America Liver Cancer Diagnostic Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Latin America Liver Cancer Diagnostic Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. Brazil
       8.3.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
       8.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.4. Argentina
       8.4.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
       8.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.5. Rest of Latin America
       8.5.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
       8.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 9. MIDDLE EAST LIVER CANCER DIAGNOSTIC MARKET BY COUNTRY

9.1. Middle East Liver Cancer Diagnostic Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Middle East Liver Cancer Diagnostic Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. Saudi Arabia
       9.3.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
       9.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.4. UAE
       9.4.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
       9.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.5. Rest of Middle East
       9.5.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
       9.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 10. AFRICA LIVER CANCER DIAGNOSTIC MARKET BY COUNTRY

10.1. Africa Liver Cancer Diagnostic Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Africa Liver Cancer Diagnostic Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. South Africa
         10.3.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
         10.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.4. Egypt
         10.4.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
         10.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.5. Rest of Africa
         10.5.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
         10.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 11. COMPANY PROFILE

11.1. Thermo Fisher Scientific
         11.1.1. Company Snapshot
         11.1.2. Overview
         11.1.3. Financial Overview
         11.1.4. Product Portfolio
         11.1.5. Key Developments
         11.1.6. Strategies
11.2. Illumina, Inc.
         11.2.1. Company Snapshot
         11.2.2. Overview
         11.2.3. Financial Overview
         11.2.4. Product Portfolio
         11.2.5. Key Developments
         11.2.6. Strategies
11.3. Siemens Healthcare GmbH
         11.3.1. Company Snapshot
         11.3.2. Overview
         11.3.3. Financial Overview
         11.3.4. Product Portfolio
         11.3.5. Key Developments
         11.3.6. Strategies
11.4. Qiagen
         11.4.1. Company Snapshot
         11.4.2. Overview
         11.4.3. Financial Overview
         11.4.4. Product Portfolio
         11.4.5. Key Developments
         11.4.6. Strategies
11.5. F. Hoffmann-La Roche Ltd.
         11.5.1. Company Snapshot
         11.5.2. Overview
         11.5.3. Financial Overview
         11.5.4. Product Portfolio
         11.5.5. Key Developments
         11.5.6. Strategies
11.6. Others
         11.6.1. Company Snapshot
         11.6.2. Overview
         11.6.3. Financial Overview
         11.6.4. Product Portfolio
         11.6.5. Key Developments
         11.6.6. Strategies

CHAPTER 12. RESEARCH APPROACH

12.1. Research Methodology
         12.1.1. Initial Data Search
         12.1.2. Secondary Research
         12.1.3. Primary Research
12.2. Assumptions and Scope

Cart Summary